| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Koichi Yamashita | |
| Kazuhiro Hanazaki | |||
| Hiromichi Maeda | |||
| Takehiro Okabayashi | |||
| Tomoaki Yatabe | |||
| P2860 | cites work | High-dose insulin therapy attenuates systemic inflammatory response in coronary artery bypass grafting patients | Q46523593 |
| Distal pancreatectomy: incidence of postoperative diabetes | Q46548862 | ||
| Risk factors for surgical site infection following orthopaedic spinal operations | Q46825774 | ||
| The accuracy of a continuous blood glucose monitor during surgery. | Q46828289 | ||
| Continuous post-operative blood glucose monitoring and control using a closed-loop system in patients undergoing hepatic resection. | Q46952469 | ||
| Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man. | Q54379531 | ||
| Reversal of abnormal glucose metabolism in chronic pancreatitis by administration of pancreatic polypeptide | Q70010566 | ||
| Role of gluconeogenesis in epinephrine-stimulated hepatic glucose production in humans | Q71020517 | ||
| Distal pancreatectomy: indications and outcomes in 235 patients | Q77425349 | ||
| Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality | Q80152130 | ||
| Glucose transport and sensing in the maintenance of glucose homeostasis and metabolic harmony | Q24548698 | ||
| Effects of hyperglycemia and insulin therapy on high mobility group box 1 in endotoxin-induced acute lung injury in a rat model | Q28580503 | ||
| Intensive insulin therapy in critically ill patients | Q29618795 | ||
| Diabetes, hyperglycemia, and infections | Q30447021 | ||
| Benefits and risks of tight glucose control in critically ill adults: a meta-analysis | Q33363493 | ||
| Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data | Q33421648 | ||
| Perioperative glycemic control and the risk of infectious complications in a cohort of adults with diabetes | Q33729996 | ||
| Pancreatic resection: effects on glucose metabolism | Q34245801 | ||
| Hepatocytes: critical for glucose homeostasis | Q35733130 | ||
| Total pancreatectomy: indications, operative technique, and postoperative sequelae | Q36772461 | ||
| Outcomes following resection of pancreatic adenocarcinoma: 20-year experience at a single institution | Q37277964 | ||
| Surgical outcomes following pancreatic resection at a low-volume community hospital: do all patients need to be sent to a regional cancer center? | Q37420952 | ||
| Long-term results of distal pancreatectomy for chronic pancreatitis in 90 patients | Q39401539 | ||
| Glucagon physiology and pathophysiology | Q40015085 | ||
| Regulation of protein metabolism during stress | Q40428914 | ||
| Endocrine Pancreas: Three-Dimensional Reconstruction Shows Two Types of Islets of Langerhans | Q41138694 | ||
| Identification of a lobe in the adult human pancreas rich in pancreatic polypeptide | Q41169370 | ||
| Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial | Q42164798 | ||
| Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes | Q42462890 | ||
| Continuous postoperative blood glucose monitoring and control by artificial pancreas in patients having pancreatic resection: a prospective randomized clinical trial | Q43258590 | ||
| Artificial endocrine pancreas | Q43731603 | ||
| Early postoperative glucose control predicts nosocomial infection rate in diabetic patients | Q44067972 | ||
| Pancreatic polypeptide administration reduces insulin requirements of artificial pancreas in pancreatectomized dogs | Q45219670 | ||
| Intensive versus conventional glucose control in critically ill patients | Q46076336 | ||
| Accuracy and reliability of continuous blood glucose monitor in post-surgical patients | Q46229486 | ||
| P433 | issue | 33 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreas | Q9618 |
| Insulin Therapy | Q2002370 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 4111-4115 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Perioperative intensive insulin therapy using artificial endocrine pancreas in patients undergoing pancreatectomy | |
| P478 | volume | 15 |
| Q38819246 | Comparison between a novel and conventional artificial pancreas for perioperative glycemic control using a closed-loop system. |
| Q33810383 | Inhalable sustained-release formulation of glucagon: in vitro amyloidogenic and inhalation properties, and in vivo absorption and bioactivity |
| Q50075179 | Management of Type 1 Diabetes in the Hospital Setting |
| Q38033152 | Tight glycemic control using an artificial endocrine pancreas may play an important role in preventing infection after pancreatic resection |
| Q26852360 | Vascular Glucose Sensor Symposium: Continuous Glucose Monitoring Systems (CGMS) for Hospitalized and Ambulatory Patients at Risk for Hyperglycemia, Hypoglycemia, and Glycemic Variability |
Search more.